610 results on '"Meads, David"'
Search Results
2. Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation
3. COVID-19 and EQ-5D-5L health state valuation
4. Something for Everybody? Assessing the Suitability of AAC Systems for Children Using Stated Preference Methods
5. Decision Making About Disease-Modifying Treatments for Relapsing-Remitting Multiple Sclerosis: Stated Preferences and Real-World Choices
6. How is overall survival assessed in randomised clinical trials in cancer and are subsequent treatment lines considered? A systematic review
7. A cluster randomised controlled trial, process and economic evaluation of quality improvement collaboratives aligned to a national audit to improve the care for people with diabetes (EQUIPD): study protocol
8. UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study Protocol
9. Modelling decay in effectiveness for evaluation of behaviour change interventions: a tutorial for public health economists
10. Assessing the comparative feasibility, acceptability and equivalence of videoconference interviews and face-to-face interviews using the time trade-off technique
11. Access to palliative care medicines in the community: An evaluation of practice and costs using case studies of service models in England
12. Does providing everyone with free-of-charge organised exercise opportunities work in public health?
13. Transforming discrete choice experiment latent scale values for EQ-5D-3L using the visual analogue scale
14. Exploring self-report and proxy-report quality-of-life measures for people living with dementia in care homes
15. Taking a local government perspective for economic evaluation of a population-level programme to promote exercise
16. An International Comparison of EQ-5D-5L and EQ-5D-3L for Use in Cost-Effectiveness Analysis
17. Attribute Selection for a Discrete Choice Experiment Incorporating a Best-Worst Scaling Survey
18. Characterising heterogeneity and the role of attitudes in patient preferences: A case study in preferences for outpatient parenteral intravenous antimicrobial therapy (OPAT) services
19. An economic framework for user financial incentives for health behaviour change
20. Temporary treatment cessation compared with continuation of tyrosine kinase inhibitors for adults with renal cancer: the STAR non-inferiority RCT.
21. Patient influence on general practice service improvement decision making: a participatory research mixed-methods intervention study.
22. Ixazomib with cyclophosphamide and dexamethasone in relapsed or refractory myeloma: MUKeight phase II randomised controlled trial results
23. Modelling the impact of physical activity on public health: A review and critique
24. UK General Population Utility Values for the SIDECAR-D Instrument Measuring the Impact of Caring for People With Dementia
25. The Impact of Reproductive Issues on Preferences of Women with Relapsing Multiple Sclerosis for Disease-Modifying Treatments
26. Healthcare utilization and productivity loss in glioma patients and family caregivers: the impact of treatable psychological symptoms
27. Cost-Effectiveness of Dementia Care Mapping in Care-Home Settings: Evaluation of a Randomised Controlled Trial
28. Changing the eligibility criteria for welfare payments at the end of life – a budget impact analysis for England and Wales
29. Levofloxacin prophylaxis in patients with newly diagnosed myeloma (TEAMM): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial
30. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L
31. Cost-Effectiveness of Docetaxel and Paclitaxel for Adjuvant Treatment of Early Breast Cancer: Adaptation of a Model-Based Economic Evaluation From the United Kingdom to South Africa
32. Safety and efficacy of co-careldopa as an add-on therapy to occupational and physical therapy in patients after stroke (DARS): a randomised, double-blind, placebo-controlled trial
33. Understanding treatment decisions from the perspective of people with relapsing remitting multiple Sclerosis: A critical interpretive synthesis
34. Adapting the EQ-5D-3L for adults with mild to moderate learning disabilities.
35. Patient influence on general practice service improvement decision making: a participatory research mixed-methods intervention study
36. The informal carer experience during the COVID-19 pandemic: Mental health, loneliness and financial (in)-security
37. How do aggregated patient-reported outcome measures data stimulate health care improvement? A realist synthesis
38. Identification and appraisal of outcome measures used to evaluate hypodontia care: A systematic review
39. EQ-5D-5L versus EQ-5D-3L: The Impact on Cost Effectiveness in the United Kingdom
40. Development of a Discrete-Choice Experiment (DCE) to Elicit Adolescent and Parent Preferences for Hypodontia Treatment
41. BJS 1 The impact of postoperative complications on quality of life after major abdominal surgery: An analysis of the Perioperative Quality Improvement database
42. What About Informal Carers and Families?
43. Supporting patient access to medicines in community palliative care: on-line survey of health professionals’ practice, perceived effectiveness and influencing factors
44. Equity and the financial costs of informal caregiving in palliative care: a critical debate
45. What factors affect patients’ access to healthcare? Protocol for an overview of systematic reviews
46. Impact of in-hospital postoperative complications on quality of life up to 12 months after major abdominal surgery
47. Something for everybody? Assessing the suitability of AAC systems for children using stated preference methods
48. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial
49. COVID-19 and EQ-5D-5L health state valuation
50. Effect of tight control of inflammation in early psoriatic arthritis (TICOPA): a UK multicentre, open-label, randomised controlled trial
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.